Abstract

Diabetes mellitus type II and obesity are two important causes of death in modern society. They are characterized by low-grade chronic inflammation and metabolic dysfunction (meta-inflammation), which is observed in all tissues involved in energy homeostasis. A substantial body of evidence has established an important role for macrophages in these tissues during the development of diabetes mellitus type II and obesity. Macrophages can activate into specialized subsets by cues from their microenvironment to handle a variety of tasks. Many different subsets have been described and in diabetes/obesity literature two main classifications are widely used that are also defined by differential metabolic reprogramming taking place to fuel their main functions. Classically activated, pro-inflammatory macrophages (often referred to as M1) favor glycolysis, produce lactate instead of metabolizing pyruvate to acetyl-CoA, and have a tricarboxylic acid cycle that is interrupted at two points. Alternatively activated macrophages (often referred to as M2) mainly use beta-oxidation of fatty acids and oxidative phosphorylation to create energy-rich molecules such as ATP and are involved in tissue repair and downregulation of inflammation. Since diabetes type II and obesity are characterized by metabolic alterations at the organism level, these alterations may also induce changes in macrophage metabolism resulting in unique macrophage activation patterns in diabetes and obesity. This review describes the interactions between metabolic reprogramming of macrophages and conditions of metabolic dysfunction like diabetes and obesity. We also focus on different possibilities of measuring a range of metabolites intra-and extracellularly in a precise and comprehensive manner to better identify the subsets of polarized macrophages that are unique to diabetes and obesity. Advantages and disadvantages of the currently most widely used metabolite analysis approaches are highlighted. We further describe how their combined use may serve to provide a comprehensive overview of the metabolic changes that take place intracellularly during macrophage activation in conditions like diabetes and obesity.

Highlights

  • Diabetes mellitus type II (DMTII) is one of the main causes of death in modern society according to the World Health Organization [1]

  • This review aims to summarize what is currently known about macrophage activation in DMTII-related meta- inflammation, how changes in intracellular metabolism are influenced by the changed presence in extracellular nutrients and metabolites, and how fluctuations in key metabolic intermediates could play a role in cellular processes like gene expression

  • Studies have shown a higher number of macrophages in white adipose tissue of obese subjects compared to people of normal body mass index (BMI), going from 10% of total cells to more than 50% [19]

Read more

Summary

Introduction

Diabetes mellitus type II (DMTII) is one of the main causes of death in modern society according to the World Health Organization [1]. It correlates with long-term complications that include nephropathy, peripheral neuropathy, and cardiovascular disease. DMTII is often linked to obesity and both are associated with metabolic syndrome, which encompasses conditions such as high blood pressure, excess body fat around the waist, high blood sugar, high serum cholesterol or triglyceride levels, and low high-density lipoprotein (HDL) cholesterol. Metabolic syndrome is characterized by low-grade chronic inflammation (metainflammation) [4] in all tissues involved in energy homeostasis, including adipose tissue, pancreatic islets, and liver [5]. Studies have shown that the metabolic consequences of adipose tissue dysfunction increase mortality in patients with DMTII, emphasizing the importance of meta-inflammation in the context of DMTII [6]

Objectives
Findings
Methods
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call